• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗精神病药物和选择性D3拮抗剂对由PD 128907和阿扑吗啡诱导的预脉冲抑制缺陷的影响。

Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine.

作者信息

Zhang Min, Ballard Michael E, Unger Liliane V, Haupt Andreas, Gross Gerhard, Decker Michael W, Drescher Karla U, Rueter Lynne E

机构信息

Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064, USA.

出版信息

Behav Brain Res. 2007 Aug 22;182(1):1-11. doi: 10.1016/j.bbr.2007.04.021. Epub 2007 May 1.

DOI:10.1016/j.bbr.2007.04.021
PMID:17570538
Abstract

Rats treated with apomorphine and amphetamine display sensorimotor gating impairments, as measured by prepulse inhibition (PPI), and these impairments can be reversed by antipsychotic treatment. However, it remains unknown whether the dopamine (DA) D(3) receptor plays a role in mediating these effects on PPI, as none of these DA agonists or antipsychotics are exclusively selective at either D(2) or D(3) receptors. To address this question, the current study was designed to investigate whether antipsychotic drugs and selective D(3) antagonists could block the PPI-disruptive effects of PD 128907 (a preferential D(3) agonist) and apomorphine. We found that the effect of PD 128907 on PPI in rats could be antagonized by risperidone, clozapine, and the selective D(3) antagonists SB 277011 and A-691990, but not by raclopride or haloperidol, while the apomorphine-induced PPI deficit could be reversed by risperidone, clozapine and haloperidol, but not by SB 2770111 and A-691990. These results suggest that the D(3) receptor does not mediate apomorphine-induced disruption of PPI in rats, however, given the findings that PD 128907 elicited a PPI-disruptive effect that was blocked by selective D(3) antagonists, a role of D(3) receptor in mediating PPI in rats cannot be ruled out. The possible mechanisms of D(3) receptor involvement in PPI are discussed.

摘要

用阿扑吗啡和苯丙胺处理的大鼠表现出感觉运动门控障碍,这通过前脉冲抑制(PPI)来衡量,并且这些障碍可通过抗精神病药物治疗得到逆转。然而,多巴胺(DA)D(3)受体是否在介导这些对PPI的作用中发挥作用仍不清楚,因为这些DA激动剂或抗精神病药物都不是仅对D(2)或D(3)受体具有选择性。为了解决这个问题,本研究旨在调查抗精神病药物和选择性D(3)拮抗剂是否可以阻断PD 128907(一种优先的D(3)激动剂)和阿扑吗啡对PPI的破坏作用。我们发现,利培酮、氯氮平以及选择性D(3)拮抗剂SB 277011和A-691990可以拮抗PD 128907对大鼠PPI的影响,但雷氯必利或氟哌啶醇则不能,而阿扑吗啡诱导的PPI缺陷可被利培酮、氯氮平和氟哌啶醇逆转,但SB 277011和A-691990则不能。这些结果表明,D(3)受体并不介导阿扑吗啡诱导的大鼠PPI破坏,然而,鉴于PD 128907引起的PPI破坏作用被选择性D(3)拮抗剂阻断的发现,不能排除D(3)受体在介导大鼠PPI中的作用。本文讨论了D(3)受体参与PPI的可能机制。

相似文献

1
Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine.抗精神病药物和选择性D3拮抗剂对由PD 128907和阿扑吗啡诱导的预脉冲抑制缺陷的影响。
Behav Brain Res. 2007 Aug 22;182(1):1-11. doi: 10.1016/j.bbr.2007.04.021. Epub 2007 May 1.
2
Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.在有利于环境条件作用的范式中,重复给予多巴胺激动剂所产生的感觉运动门控效应。
Psychopharmacology (Berl). 2002 Jul;162(2):138-46. doi: 10.1007/s00213-002-1026-1. Epub 2002 May 9.
3
Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats.在大鼠前脉冲抑制破坏的药理学模型中,伊潘立酮可减少感觉运动门控缺陷,但在发育模型中则不然。
Neuropharmacology. 2006 Sep;51(3):457-65. doi: 10.1016/j.neuropharm.2006.04.004. Epub 2006 Jun 8.
4
Effects of LU-111995 in three models of disrupted prepulse inhibition in rats.LU-111995对大鼠三种前脉冲抑制破坏模型的影响。
J Pharmacol Exp Ther. 1999 Aug;290(2):716-24.
5
Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle.联合使用α2-肾上腺素能受体/D2多巴胺受体阻滞剂无法重现氯氮平逆转苯环己哌啶诱导的惊吓前脉冲抑制缺陷的能力。
Psychopharmacology (Berl). 2001 Dec;159(1):105-10. doi: 10.1007/s002130100905. Epub 2001 Sep 11.
6
Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist.苯环利定引起的惊吓前脉冲抑制缺陷可被α-1肾上腺素能拮抗剂哌唑嗪阻断。
J Pharmacol Exp Ther. 1997 Nov;283(2):666-74.
7
Agmatine disrupts prepulse inhibition of acoustic startle reflex in rats.胍丁胺破坏大鼠声刺激反射的预备性抑制。
J Psychopharmacol. 2010 Jun;24(6):923-9. doi: 10.1177/0269881109102533. Epub 2009 Mar 12.
8
Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat.舒必利、雷氯必利、SCH 23390和氯氮平对阿扑吗啡抑制大鼠惊吓反应感觉运动门控的影响。
J Pharmacol Exp Ther. 1991 Feb;256(2):530-6.
9
Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.新型抗精神病药物对阿扑吗啡诱导的预脉冲抑制破坏的作用:5-羟色胺5-HT1A受体激活与多巴胺D2受体阻断联合的影响
Neuropsychopharmacology. 2006 Sep;31(9):1900-9. doi: 10.1038/sj.npp.1301015. Epub 2006 Jan 18.
10
SCH 23390 in the prefrontal cortex enhances the effect of apomorphine on prepulse inhibition of rats.前额叶皮质中的SCH 23390增强了阿扑吗啡对大鼠前脉冲抑制的作用。
Neuropharmacology. 2006 Sep;51(3):438-46. doi: 10.1016/j.neuropharm.2006.04.002. Epub 2006 Jun 5.

引用本文的文献

1
Neurophysiological treatment effects of mesdopetam, pimavanserin and clozapine in a rodent model of Parkinson's disease psychosis.在帕金森病精神病的啮齿动物模型中,mesdopetam、pimavanserin 和氯氮平的神经生理治疗效果。
Neurotherapeutics. 2024 Mar;21(2):e00334. doi: 10.1016/j.neurot.2024.e00334. Epub 2024 Feb 16.
2
Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders.神经元多巴胺D3受体:对临床前研究和中枢神经系统疾病的转化意义
Biomolecules. 2021 Jan 14;11(1):104. doi: 10.3390/biom11010104.
3
Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?
多巴胺 D3 受体:帕金森病发病机制和治疗中的被忽视的参与者?
Ageing Res Rev. 2020 Jan;57:100994. doi: 10.1016/j.arr.2019.100994. Epub 2019 Nov 22.
4
Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases.多巴胺D3受体拮抗剂作为治疗神经疾病的潜在疗法。
Front Neurosci. 2016 Oct 5;10:451. doi: 10.3389/fnins.2016.00451. eCollection 2016.
5
Y-QA31, a novel dopamine D3 receptor antagonist, exhibits antipsychotic-like properties in preclinical animal models of schizophrenia.Y-QA31是一种新型多巴胺D3受体拮抗剂,在精神分裂症的临床前动物模型中表现出类似抗精神病的特性。
Acta Pharmacol Sin. 2016 Mar;37(3):322-33. doi: 10.1038/aps.2015.105. Epub 2016 Jan 18.
6
Stimulation of Dopamine D3 Receptor Attenuates Renal Ischemia-Reperfusion Injury via Increased Linkage With Gα12.多巴胺D3受体的刺激通过增加与Gα12的联系减轻肾缺血-再灌注损伤。
Transplantation. 2015 Nov;99(11):2274-84. doi: 10.1097/TP.0000000000000762.
7
Stereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in rats.普拉克索对大鼠感觉运动门控影响的立体化学和神经解剖选择性。
Brain Res. 2012 Feb 9;1437:69-76. doi: 10.1016/j.brainres.2011.12.007. Epub 2011 Dec 13.
8
Disparate effects of pramipexole on locomotor activity and sensorimotor gating in Sprague-Dawley rats.普拉克索对 Sprague-Dawley 大鼠运动活动和感觉运动门控的不同影响。
Pharmacol Biochem Behav. 2011 Oct;99(4):634-8. doi: 10.1016/j.pbb.2011.06.002. Epub 2011 Jun 12.
9
The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats.多巴胺 D2 激动剂 sumanirole 对大鼠前脉冲抑制的影响。
Eur Neuropsychopharmacol. 2010 Jun;20(6):421-5. doi: 10.1016/j.euroneuro.2010.02.011. Epub 2010 Mar 25.
10
Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44.利用预脉冲抑制检测功能性D3受体拮抗作用:WC10和WC44的作用
Pharmacol Biochem Behav. 2009 Aug;93(2):141-7. doi: 10.1016/j.pbb.2009.04.022. Epub 2009 May 6.